Israel Englander Innate Pharma Sa Put Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IPHA
# of Institutions
11Shares Held
127KCall Options Held
0Put Options Held
0-
Exchange Traded Concepts, LLC62.8KShares$129,2690.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$89,6590.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il11.9KShares$24,4170.0% of portfolio
-
Gamma Investing LLC Foster City, CA3.98KShares$8,1880.01% of portfolio
-
Ubs Group Ag3.51KShares$7,2300.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $165M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...